Buy JB Chemicals and Pharmaceuticals; target of Rs 1356: Dolat Capital Market
Dolat Capital Market is bullish on JB Chemicals and Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1356 in its research report dated March 02, 2021.
March 04, 2021 / 02:09 PM IST
Dolat Capital Market's research report on JB Chemicals and Pharmaceuticals
JBCPL hosted virtual analyst meet to share its mid to long term vision post the change in management after the buyout by PE firm KKR (54%) in July’20. The new management laid out a 6-point framework for sustainable mid-teens growth via therapy diversification, productivity improvement, leveraging existing capabilities in CMO, exploring M&A (brands, portfolio) and focus on deepening existing base through digitization.
At CMP, stock trades at 24.7x FY22E and 21x FY23E EPS of Rs48.8 and Rs56.7 respectively
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.